ID   SIAH2_RAT               Reviewed;         325 AA.
AC   Q8R4T2; Q920M8;
DT   26-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   26-APR-2004, sequence version 2.
DT   24-JUL-2024, entry version 146.
DE   RecName: Full=E3 ubiquitin-protein ligase SIAH2;
DE            EC=2.3.2.27 {ECO:0000269|PubMed:11786535};
DE   AltName: Full=RING-type E3 ubiquitin transferase SIAH2 {ECO:0000305};
DE   AltName: Full=Seven in absentia homolog 2;
DE            Short=Siah-2;
GN   Name=Siah2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Yamaguchi A., Hori O., Tohyama M.;
RT   "Rat Siah1A.";
RL   Submitted (AUG-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 71-325, FUNCTION IN SYP DEGRADATION, AND
RP   INTERACTION WITH UBE2E2.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=11786535; DOI=10.1074/jbc.m107857200;
RA   Wheeler T.C., Chin L.-S., Li Y., Roudabush F.L., Li L.;
RT   "Regulation of synaptophysin degradation by mammalian homologues of Seven
RT   in Absentia.";
RL   J. Biol. Chem. 277:10273-10282(2002).
RN   [3]
RP   INTERACTION WITH SNCAIP.
RX   PubMed=15064394; DOI=10.1073/pnas.0401081101;
RA   Liani E., Eyal A., Avraham E., Shemer R., Szargel R., Berg D.,
RA   Bornemann A., Riess O., Ross C.A., Rott R., Engelender S.;
RT   "Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence
RT   in cellular inclusions and Lewy bodies imply a role in Parkinson's
RT   disease.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:5500-5505(2004).
RN   [4]
RP   SUBCELLULAR LOCATION, INTERACTION WITH SNCAIP, AND TISSUE SPECIFICITY.
RX   PubMed=19224863; DOI=10.1074/jbc.m805990200;
RA   Szargel R., Rott R., Eyal A., Haskin J., Shani V., Balan L., Wolosker H.,
RA   Engelender S.;
RT   "Synphilin-1A inhibits seven in absentia homolog (SIAH) and modulates
RT   alpha-synuclein monoubiquitylation and inclusion formation.";
RL   J. Biol. Chem. 284:11706-11716(2009).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase that mediates ubiquitination and
CC       subsequent proteasomal degradation of target proteins
CC       (PubMed:11786535). E3 ubiquitin ligases accept ubiquitin from an E2
CC       ubiquitin-conjugating enzyme in the form of a thioester and then
CC       directly transfers the ubiquitin to targeted substrates
CC       (PubMed:11786535). Mediates E3 ubiquitin ligase activity either through
CC       direct binding to substrates or by functioning as the essential RING
CC       domain subunit of larger E3 complexes (By similarity). Mediates
CC       ubiquitination and proteasomal degradation of DYRK2 in response to
CC       hypoxia (By similarity). Promotes monoubiquitination of SNCA (By
CC       similarity). Triggers the ubiquitin-mediated degradation of many
CC       substrates, including proteins involved in transcription regulation
CC       (GPS2, POU2AF1, PML, NCOR1), a cell surface receptor (DCC), an
CC       antiapoptotic protein (BAG1), and a protein involved in synaptic
CC       vesicle function in neurons (SYP) (PubMed:11786535). It is thereby
CC       involved in apoptosis, tumor suppression, cell cycle, transcription and
CC       signaling processes (By similarity). Has some overlapping function with
CC       SIAH1 (By similarity). Triggers the ubiquitin-mediated degradation of
CC       TRAF2, whereas SIAH1 does not (By similarity). Regulates cellular clock
CC       function via ubiquitination of circadian transcriptional repressors
CC       NR1D1 and NR1D2 leading to their proteasomal degradation. Plays an
CC       important role in mediating the rhythmic degradation/clearance of NR1D1
CC       and NR1D2 contributing to their circadian profile of protein abundance
CC       (By similarity). Mediates ubiquitination and degradation of EGLN2 and
CC       EGLN3 in response to the unfolded protein response (UPR), leading to
CC       their degradation and subsequent stabilization of ATF4 (By similarity).
CC       Also part of the Wnt signaling pathway in which it mediates the Wnt-
CC       induced ubiquitin-mediated proteasomal degradation of AXIN1 (By
CC       similarity). {ECO:0000250|UniProtKB:O43255,
CC       ECO:0000250|UniProtKB:Q06986, ECO:0000269|PubMed:11786535}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27; Evidence={ECO:0000269|PubMed:11786535};
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000269|PubMed:11786535}.
CC   -!- SUBUNIT: Homodimer (By similarity). Interacts with VAV1, without
CC       mediating its ubiquitin-mediated degradation (By similarity). Probable
CC       component of some large E3 complex possibly composed of UBE2D1, SIAH2,
CC       CACYBP/SIP, SKP1, APC and TBL1X (By similarity). Interacts with UBE2I
CC       (By similarity). Interacts with UBE2E2 (PubMed:11786535). Interacts
CC       with PEG10, which may inhibit its activity (By similarity). Interacts
CC       with PEG3 and EGLN2 (By similarity). Interacts with DYRK2 (By
CC       similarity). Interacts with SNCAIP (PubMed:15064394, PubMed:19224863).
CC       Interacts with NR1D1 and NR1D2 (By similarity). Interacts with DCC (By
CC       similarity). Interacts with AXIN1. {ECO:0000250|UniProtKB:O43255,
CC       ECO:0000250|UniProtKB:Q06986, ECO:0000269|PubMed:11786535,
CC       ECO:0000269|PubMed:15064394, ECO:0000269|PubMed:19224863}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19224863}. Nucleus
CC       {ECO:0000305|PubMed:19224863}. Note=Predominantly cytoplasmic.
CC       Partially nuclear. {ECO:0000250|UniProtKB:O43255}.
CC   -!- TISSUE SPECIFICITY: Detected in brain (at protein level).
CC       {ECO:0000269|PubMed:19224863}.
CC   -!- DOMAIN: The RING-type zinc finger domain is essential for ubiquitin
CC       ligase activity.
CC   -!- DOMAIN: The SBD domain (substrate-binding domain) mediates the
CC       homodimerization and the interaction with substrate proteins. It is
CC       related to the TRAF family. {ECO:0000250|UniProtKB:P61092}.
CC   -!- PTM: Phosphorylated at Thr-24 and Ser-29 by MAPK14, which mediates the
CC       degradation by the proteasome of EGLN3. Phosphorylated at Ser-29 by
CC       DYRK2; this increases the ubiquitin ligase activity and promotes
CC       degradation of EGLN3 (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the SINA (Seven in absentia) family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB067815; BAB70754.1; -; mRNA.
DR   EMBL; AF389477; AAL91363.1; -; mRNA.
DR   RefSeq; NP_604452.1; NM_134457.1.
DR   AlphaFoldDB; Q8R4T2; -.
DR   SMR; Q8R4T2; -.
DR   BioGRID; 250807; 2.
DR   STRING; 10116.ENSRNOP00000018488; -.
DR   PhosphoSitePlus; Q8R4T2; -.
DR   PaxDb; 10116-ENSRNOP00000018488; -.
DR   Ensembl; ENSRNOT00000018488.3; ENSRNOP00000018488.1; ENSRNOG00000013703.5.
DR   Ensembl; ENSRNOT00055031497; ENSRNOP00055025433; ENSRNOG00055018534.
DR   Ensembl; ENSRNOT00060008113; ENSRNOP00060006081; ENSRNOG00060004879.
DR   Ensembl; ENSRNOT00065041326; ENSRNOP00065033756; ENSRNOG00065024096.
DR   GeneID; 140593; -.
DR   KEGG; rno:140593; -.
DR   UCSC; RGD:620778; rat.
DR   AGR; RGD:620778; -.
DR   CTD; 6478; -.
DR   RGD; 620778; Siah2.
DR   eggNOG; KOG3002; Eukaryota.
DR   GeneTree; ENSGT00940000159812; -.
DR   HOGENOM; CLU_028215_0_0_1; -.
DR   InParanoid; Q8R4T2; -.
DR   OrthoDB; 222086at2759; -.
DR   PhylomeDB; Q8R4T2; -.
DR   Reactome; R-RNO-5689880; Ub-specific processing proteases.
DR   Reactome; R-RNO-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   UniPathway; UPA00143; -.
DR   PRO; PR:Q8R4T2; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Bgee; ENSRNOG00000013703; Expressed in testis and 20 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0005769; C:early endosome; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR   GO; GO:0031624; F:ubiquitin conjugating enzyme binding; IDA:RGD.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; ISS:UniProtKB.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; ISS:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0060070; P:canonical Wnt signaling pathway; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISO:RGD.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; ISO:RGD.
DR   GO; GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   GO; GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway.
DR   GO; GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB.
DR   GO; GO:0031396; P:regulation of protein ubiquitination; IDA:RGD.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; ISS:UniProtKB.
DR   CDD; cd16752; RING-HC_SIAH2; 1.
DR   CDD; cd03829; Sina; 1.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 2.
DR   InterPro; IPR018121; 7-in-absentia-prot_TRAF-dom.
DR   InterPro; IPR004162; SINA-like_animal.
DR   InterPro; IPR049548; Sina-like_RING.
DR   InterPro; IPR008974; TRAF-like.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR013010; Znf_SIAH.
DR   PANTHER; PTHR45877; E3 UBIQUITIN-PROTEIN LIGASE SIAH2; 1.
DR   PANTHER; PTHR45877:SF4; E3 UBIQUITIN-PROTEIN LIGASE SIAH2; 1.
DR   Pfam; PF21362; Sina_RING; 1.
DR   Pfam; PF03145; Sina_TRAF; 1.
DR   Pfam; PF21361; Sina_ZnF; 1.
DR   SUPFAM; SSF57850; RING/U-box; 1.
DR   SUPFAM; SSF49599; TRAF domain-like; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
DR   PROSITE; PS51081; ZF_SIAH; 1.
PE   1: Evidence at protein level;
KW   Apoptosis; Biological rhythms; Cell cycle; Cytoplasm; Metal-binding;
KW   Nucleus; Phosphoprotein; Reference proteome; Transferase;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN           1..325
FT                   /note="E3 ubiquitin-protein ligase SIAH2"
FT                   /id="PRO_0000056170"
FT   ZN_FING         81..116
FT                   /note="RING-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   ZN_FING         134..194
FT                   /note="SIAH-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00455"
FT   REGION          1..43
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          131..323
FT                   /note="SBD"
FT                   /evidence="ECO:0000250|UniProtKB:P61092"
FT   COMPBIAS        14..32
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         139
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P61092"
FT   BINDING         146
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P61092"
FT   BINDING         158
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P61092"
FT   BINDING         162
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P61092"
FT   BINDING         169
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P61092"
FT   BINDING         176
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P61092"
FT   BINDING         188
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P61092"
FT   BINDING         193
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P61092"
FT   MOD_RES         6
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O43255"
FT   MOD_RES         16
FT                   /note="Phosphoserine; by DYRK2"
FT                   /evidence="ECO:0000250|UniProtKB:O43255"
FT   MOD_RES         24
FT                   /note="Phosphothreonine; by MAPK14"
FT                   /evidence="ECO:0000250|UniProtKB:Q06986"
FT   MOD_RES         29
FT                   /note="Phosphoserine; by DYRK2 and MAPK14"
FT                   /evidence="ECO:0000250|UniProtKB:O43255"
FT   MOD_RES         69
FT                   /note="Phosphoserine; by DYRK2"
FT                   /evidence="ECO:0000250|UniProtKB:O43255"
FT   MOD_RES         120
FT                   /note="Phosphothreonine; by DYRK2"
FT                   /evidence="ECO:0000250|UniProtKB:O43255"
SQ   SEQUENCE   325 AA;  34700 MW;  0E273AD30959982E CRC64;
     MSRPSSTGPS ANKPCSKQPP PPQTPHAPSP AAPPAAATIS AAGPGSSAVP AAAAVISGPG
     AGGGAGPVSP QHHELTSLFE CPVCFDYVLP PILQCQAGHL VCNQCRQKLS CCPTCRGALT
     PSIRNLAMEK VASAVLFPCK YATTGCSLTL HHTEKPEHED ICEYRPYSCP CPGASCKWQG
     SLEAVMSHLM HAHKSITTLQ GEDIVFLATD INLPGAVDWV MMQSCFGHHF MLVLEKQEKY
     EGHQQFFAIV LLIGTRKQAE NFAYRLELNG NRRRLTWEAT PRSIHDGVAA AIMNSDCLVF
     DTAIAHLFAD NGNLGINVTI STCCQ
//
